Showing results (191-200 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 29, 2021
Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis RegistryMette Nørgaard, Katalin Veres, Finn T Sellebjerg, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension studyPeter Rieckmann, Robert Zivadinov, Alexey Boyko, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2021
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosisAlok Bhan, Cecilie Jacobsen, Ingvild Dalen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 12, 2021
The prevalence of epileptic seizures in multiple sclerosis in a large tertiary hospital in AustraliaSuyi Ooi, Tomas Kalincik, Piero Perucca, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 12, 2021
Quality of life in multiple sclerosis: The differential impact of motor and cognitive fatigueSabina David Ruban, Claudia Christina Hilt, Thor Petersen
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 9, 2022
Work difficulties in people with multiple sclerosis: The role of anxiety, depression and copingEea van Egmond, K van der Hiele, Dam van Gorp, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 31, 2022
Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic reviewNegar Molazadeh, Gauruv Bose, Itay Lotan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2025
Deep cervical lymph node volume decreases following B-cell depletion therapyNikhil Lele, Sathish K Dundamadappa, Christopher C Hemond
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 26, 2021
Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in ArgentinaEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2021
A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatmentMaria-Elizabeth Baeva, Philip Boris Baev, Jill Nelson, et al.
Pageof 61